Why CRISPR Therapeutics Stock Is Soaring Today

Following ongoing tensions related to Russia's invasion of Ukraine, surging gas prices, and high inflation, stocks posted their worst sell-off since October 2020 on Monday. The market saw some rebound momentum in Tuesday's trading, and CRISPR Therapeutics stock also appears to have gotten a significant boost from an interview given by the company's CEO at a conference yesterday.